Annovis Bio

Annovis Bio’s Buntanetap Trial for Alzheimer’s Disease Gets Green Light from DSMB: A Positive Step Forward

BERWYN, PA — Annovis Bio, Inc. (NYSE: ANVS), a biopharmaceutical company focused on developing novel treatments for neurodegenerative diseases, recently announced a significant milestone in its clinical trial journey. The …

Annovis Bio’s Buntanetap Trial for Alzheimer’s Disease Gets Green Light from DSMB: A Positive Step Forward Read More
Trinseo

Trinseo Streamlines Global Operations: A Strategic Move Towards Sustainability-Driven Innovation

WAYNE, PA — In a pivotal shift towards sustainability-driven innovation, Trinseo (NYSE: TSE), a global provider of specialty material solutions, recently announced the completion of its strategic network optimization initiative. …

Trinseo Streamlines Global Operations: A Strategic Move Towards Sustainability-Driven Innovation Read More



AMETEK

AMETEK, Inc. to Acquire Paragon Medical in a $1.9 Billion Deal, Marking Significant Expansion in MedTech

BERWYN, PA — AMETEK, Inc. (NYSE: AME), a manufacturer of electronic instruments and electromechanical devices, recently announced its intention to acquire Paragon Medical, a premier provider of highly engineered medical …

AMETEK, Inc. to Acquire Paragon Medical in a $1.9 Billion Deal, Marking Significant Expansion in MedTech Read More